Evidence map›Paper›PMID 41803108›Full record

ArticleNature communications2026

Epilepsy-associated FOXJ3 variants link a transcriptional program of the PTEN-mTOR pathway to neuronal specification and cortical lamination.

Haw-Yuan Cheng, Chen Liu, Chiao-Wen Nien, Hui-Chin Huang, Hong-Jun Zhao, Fang-Shin Nian, Chien Chen, Helena Martins Custodio, Sanjay M Sisodiya, Chien Lu and 15 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Haw-Yuan Cheng *Institute of Brain Science, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.ORCID 0009-0007-9398-5652
Chen Liu *Institute of Brain Science, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Chiao-Wen NienInstitute of Brain Science, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Hui-Chin HuangInstitute of Brain Science, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Hong-Jun ZhaoInstitute of Brain Science, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Fang-Shin NianInstitute of Brain Science, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Chien ChenInstitute of Brain Science, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Helena Martins CustodioResearch Department of Epilepsy, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, and Chalfont Centre for Epilepsy, Buckinghamshire, London, UK.
Sanjay M SisodiyaResearch Department of Epilepsy, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, and Chalfont Centre for Epilepsy, Buckinghamshire, London, UK.ORCID 0000-0002-1511-5893
Chien LuSchool of Medicine, National Yang Ming Chiao Tung University College of Medicine Taipei, Taipei, Taiwan.ORCID 0009-0007-2694-2847
Hsin-Hung ChenSchool of Medicine, National Yang Ming Chiao Tung University College of Medicine Taipei, Taipei, Taiwan.ORCID 0000-0001-7531-9188
Chih-Sin HsuGenomics Center for Clinical and Biotechnological Applications, Cancer and Immunology Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Wen-Chieh PiInstitute of Biochemistry and Molecular Biology, College of Life Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.ORCID 0000-0002-9777-1455
Chia-Chi ChuGraduate Institute of Medical Genomics and Proteomics, College of Medicine, National Taiwan University, Taipei, Taiwan.
Jacob Shu-Jui HsuGraduate Institute of Medical Genomics and Proteomics, College of Medicine, National Taiwan University, Taipei, Taiwan.
Pei-Lung ChenGraduate Institute of Medical Genomics and Proteomics, College of Medicine, National Taiwan University, Taipei, Taiwan.ORCID 0000-0002-5640-3074
Fu-Pang ChangDepartment of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Chien-Yi TungGenomics Center for Clinical and Biotechnological Applications, Cancer and Immunology Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.ORCID 0000-0002-1467-2575
Shen-Ju ChouNeuroscience Program of Academia Sinica (NPAS), Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan.ORCID 0000-0002-4103-7286
Shahryar AlaviDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK.ORCID 0000-0002-3484-3423
Henry HouldenDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK.ORCID 0000-0002-2866-7777
Wei-Yi ChenInstitute of Biochemistry and Molecular Biology, College of Life Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.ORCID 0000-0002-0661-6899
Yo-Tsen LiuInstitute of Brain Science, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. ytliu2@vghtpe.gov.tw.
Pei-Shan HouInstitute of Brain Science, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. pshou@nycu.edu.tw.
Jin-Wu TsaiInstitute of Brain Science, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. tsaijw@nycu.edu.tw.ORCID 0000-0003-0135-759X

Funding

National Health Research InstitutesNational Science and Technology CouncilTaipei Veterans General Hospital
6 · The paper itself

Abstract

Focal cortical dysplasia (FCD), a major cause of drug-resistant epilepsy, involves abnormal neuronal migration and cortical architecture, yet its molecular basis remains poorly defined. Here, we identify FOXJ3 pathogenic variants in patients with autosomal dominant focal epilepsy and FCD. In the developing mouse cortex, FOXJ3 declines sharply in neural progenitors after embryonic day 15.5. In utero electroporation-mediated Foxj3 knockdown in mouse brains impairs neuronal migration, disrupts cortical lamination, and alters neuronal specification, promoting upper-layer neuron production at the expense of deeper-layer neurons. ChIP-seq and scRNA-seq analyses identify Pten as a key FOXJ3 target. Notably, Pten overexpression rescues cortical defects caused by FOXJ3 deficiency. FCD-associated variant fails to upregulate Pten, leading to dysregulated mTOR signaling and enlarged neuronal soma, a hallmark of FCD. These findings suggest that mutations in FOXJ3 may cause epilepsy and FCD and define a transcriptional program that regulates the PTEN-mTOR pathway for neuronal specification and cortical lamination.

Indexed as

Cerebral CortexEpilepsyFocal Cortical DysplasiaForkhead Transcription FactorsNeuronsPTEN PhosphohydrolaseTOR Serine-Threonine KinasesAnimalsCell MovementFemaleHumansMaleMiceMutationSignal TransductionForkhead Transcription FactorsMTOR protein, humanPTEN PhosphohydrolasePten protein, mouseTOR Serine-Threonine Kinases

Identifiers

PMID41803108
PMCPMC12972129

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.